Citrus Oncology
PrivateLast Round
Grant
Apr 28, 2025
Total Funding Raised
$15,000
Momentum Score
25 /100
Company Overview
Citrus Oncology, Inc. is a virtual multi-specialty healthcare company founded in 2023 by Dr. Afreen Shariff and Aabid Shariff, PhD. The company operates a platform designed to help cancer patients manage the side effects of their treatment and pre-existing comorbidities. It provides oncologists and patients with access to a network of specialists, such as onco-endocrinologists, onco-dermatologists, and cardio-oncologists, through asynchronous consultations and video visits. The B2B2C model facilitates doctor-to-doctor consultations to provide expert recommendations within 72 hours, and also offers direct-to-patient virtual care. The goal is to reduce treatment delays, prevent hospitalizations, and improve the quality of life for cancer patients during treatment and into survivorship. The company was selected for the 2025 CancerX Accelerator program and is initially offering services in Florida with plans to expand across the United States.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Vertical SaaS, Patient Engagement, Clinical Trials, Medical AI
Business Model
B2B2C
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Citrus Oncology Comps
Public and private peers based on sector, stage, and business model.
Citrus Oncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 28, 2025 | ||||
| Grant | Oct 17, 2024 |
Citrus Oncology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NC IDEA | Grant |
Citrus Oncology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Citrus Oncology's valuation, stock price, and market status.
